Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지

Cost-of-illness Study of Asthma in Korea: Estimated from the Korea National Health Insurance Claims Database

건강보험 청구자료를 이용한 우리나라 천식환자의 질병비용부담 추계

  • Park, Choon-Seon (Health Insurance Review Agency) ;
  • Kwon, Il (National Health Personnel Licensing Examination Board) ;
  • Kang, Dae-Ryong (Department of Preventive Medicine, College of Medicine, Yonsei University) ;
  • Jung, Hye-Young (Graduate School of Public Health, Yonsei University) ;
  • Kang, Hye-Young (Graduate School of Public Health, Yonsei University)
  • 박춘선 (건강보험심사평가원) ;
  • 권일 (한국보건의료인국가시험원) ;
  • 강대룡 (연세대학교 의과대학 예방의학교실) ;
  • 정혜영 (연세대학교 보건대학원) ;
  • 강혜영 (연세대학교 보건대학원)
  • Published : 2006.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: We estimated the asthma-related health care utilization and costs in Korea from the insurer's and societal perspective. Methods: We extracted the insurance claims records from the Korea National Health Insurance claims database for determining the health care services provided to patients with asthma in 2003. Patients were defined as having asthma if they had ${\geq}$2 medical claims with diagnosis of asthma and they had been prescribed anti-asthma medicines, Annual claims records were aggeregated for each patient to produce patient-specific information on the total utilization and costs. The total asthma-related cost was the sum of the direct healthcare costs, the transportation costs for visits to health care providers and the patient's or caregivers' costs for the time spent on hospital or outpatient visits. Results: A total of 699,603people were identified as asthma patients, yielding an asthma prevalence of 1.47%. Each asthma patient had 7.56 outpatient visits, 0.01 ED visits and 0.02 admissions per year to treat asthma. The per-capita insurance-covered costs increased with age, from 128,276 Won for children aged 1 to 14 years to 270,729 Won for those aged 75 or older. The total cost in the nation varied from 121,865 million to 174,949 million Won depending on the perspectives. From a societal perspective, direct health care costs accounted for 84.9%, transportation costs for 15.1 % and time costs for 9.2% of the total costs. Conclusions: Hospitalizations and ED visits represented only a small portion of the asthma-related costs. Most of the societal burden was attributed to direct medical expenditures, with outpatient visits and medications emerging as the single largest cost components.

Keywords

References

  1. World Health Organization. Prevention of allergy and allergic asthma. 2003. Available from:URL://http://whqlibdoc.who.int/hq/2003/WHO_NMH_MNCCRA_03.2.pdf
  2. Lee SI. Trend of prevalence rate of asthma among Korean children: ISAAC study. Korean J Allergy 1996; 16(2): 172-174 (Korean)
  3. Korea Ministry of Health & Welfare. 2001 National Health and Nutrition Survey: Chronic Disease. Table 6-1, p 107 (Korean)
  4. Serra-Battlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 1998; 12(6): 1322-1326 https://doi.org/10.1183/09031936.98.12061322
  5. Herjavecz I, Nagy GB, Gyurkovits K, Magyar P, Dobos K, Nagy L, Alemao E, Ben-Joseph R. Cost, morbidity, and control of asthma in Hungary: The Hunair study. J Asthma 2003; 40(6): 673-681 https://doi.org/10.1081/JAS-120021100
  6. Bootman JL, Crown WH, Luskin AT. Oinical and economic effects of suboptimally controlled asthma. Managed Care Inteiface 2004; 17(1): 31-36
  7. Lozano P, Fishman P, Vonkorff M, Hecht J. Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization. Pediatrics 1997; 99(6): 757-764 https://doi.org/10.1542/peds.99.6.757
  8. Schwenkglenks M, Lowy A, Anderhub H, Szucs TD. Costs of asthma in a cohort of Swiss adults: Associations with exacerbation status and severity. Value Health 2003; 6(1): 75-83 https://doi.org/10.1046/j.1524-4733.2003.00206.x
  9. Lozano P, Sullivan SD, Smith DR, Weiss KB. The economic burden of asthma in US children: estimates from the national medical expenditure survey. J Allergy Clin Immunol 1999; 104(5): 957-963 https://doi.org/10.1016/S0091-6749(99)70075-8
  10. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 2000; 106(3): 493-499 https://doi.org/10.1067/mai.2000.109426
  11. Akinbami LJ, Schoendorf KC Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002; 110(2 pt 1): 315-322 https://doi.org/10.1542/peds.110.2.315
  12. Lozano P, Connell FA, Koepsell TD. Use of health services by African-American children with asthma on medicaid. JAMA 1995; 274(6): 469-473 https://doi.org/10.1001/jama.274.6.469
  13. Molken R-V, Postma MJ, Joore MA, Van Genugten MLL, Leidl R, Jager JC. Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands. Respir Med 1999; 93(11): 779-787 https://doi.org/10.1016/S0954-6111(99)90262-7
  14. Szucs TD, Anderhub H, Rutishauser M. The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J 1999; 13(2): 281-286 https://doi.org/10.1034/j.1399-3003.1999.13b10.x
  15. Ungar WJ, Coyte PC, Pharmacy medication monitoring program advisory board. Prospective study of the patient-level cost of asthma care in children. Pediatr Pulmonol 2001; 32(2): 101-108 https://doi.org/10.1002/ppul.1095
  16. Ganse EV, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, Ernst P. Persistent asthma: disease control, resource utilization and direct costs. Eur Respir J 2002; 20(2): 260-267 https://doi.org/10.1183/09031936.02.02542001
  17. Stevens CA, Tumer D, Kuehni CE, Couriel JM, Silverman M. The economic impact of preschool asthma and wheeze. Eur Respir J 2003;21(6): 1000-1006 https://doi.org/10.1183/09031936.03.00057002
  18. Weinmann S, Kamtsiuris P, Henke K-D, Wickman M, Jenner A, Wahn U. The costs of atopy and asthma in children: assessment of direct costs and their determinants in a birth cohort. Pediatr Allergy Immunol 2003; 14(1): 18-26 https://doi.org/10.1034/j.1399-3038.2003.02085.x
  19. Park JK, Kim EJ, Pyun BY, Lee SJ. An epidemiological study of bronchial asthma in children who visited emergency room. Korean J Pediatr 1989; 32(2): 215-222 (Korean)
  20. Yoon KR, Rah YH, Bae CW, Chung SJ. Analysis of risk factors of readmission to hospital for pediatric asthma. Korean J Pediatr 2000;43(4): 556-560 (Korean)
  21. Yoon HY. Variable factors in clinical management of childhood asthma. Pediair Allergy Respit Dis 2002; 12(3): 173-184 (Korean)
  22. Frank TL, Cropper JA, Hazell ML, Frank PI, Hannaford PC. Childhood asthma: healthcare resource utilisation in those with and without a diagnosis of the condition. Respir Med 2004; 98(5): 454-63 https://doi.org/10.1016/j.rmed.2003.09.020
  23. Toelle BG, Peat JK, Mellis CM, Woolcock AJ. The cost of childhood asthma to Australian families. Pediatr Pulmonol 1995; 19(6): 330-5 https://doi.org/10.1002/ppul.1950190604
  24. Bimbaum HG, Cremieux PY, Greenberg PE, LeLorier J, Ostrander JA, Venditti L. Using healthcare claims data for outcomes research and phannacoeconomic analyses. Pharmacoeconoirics 1999; 16(1): 1-8
  25. Chung BK. Socioeconomic costs of 6 diseases related to obesity [dissertation]. Seoul Nation Univ; (Korean)
  26. Chung YH, Ko SJ. Estimating socioeconomic costs of 5 leading causes of death. Korean Assoc Public Finance & Econs 2004; 18(2): 77-104 (Korean)
  27. Kim HJ, Park TK, JI SH, Kang HY, Nam CM. Analysis of socioeconomic costs of smoking in Korea. Korean J Prev Med 2001; 34(3): 183-190 (Korean)
  28. Rice DP. Cost-of-illness studies: fact or fiction. Lancet 1994; 344(8936): 1519-1520 https://doi.org/10.1016/S0140-6736(94)90342-5
  29. Kang HY, Kirn HJ, Park TK, Jee SH, Nam CM, Park HW. Economic burden of smoking in Korea. Tob Control 2003; 12(1)T 37-44 https://doi.org/10.1136/tc.12.1.37
  30. Birnbaum HG, Leong SA, Oster EF, Kinchen K, Sun P. Cost of stress urinary incontinence: a claims data analysis. Pharmacoeconomics 2004; 22(2): 95-105
  31. Colice GL, Morley MA, Asche C, Birnbaum HG. Treatment costs of community-acquired pneumonia in an employed population. Chest 2004; 125(6): 2140-2145 https://doi.org/10.1378/chest.125.6.2140
  32. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes, 2nd ed. Oxford University Press. 1997
  33. Yang BM, Kim JH, Lee TJ, Choi YJ. Developing Criteria for Estimating Standard Costs used in Economic Evaluation Studies for Medicines Seoul, Korea: Health Insurance Review Agency, 2004 (Korean)
  34. Jung HJ. Estimating non-covered medical cost Health Insurance Forum 2002; 1(3): 73-97 (Korean)
  35. Korea National Statistics Office. Consumer price index. Available from: URL : http://kosis.nso.go.kr/cgi-binlsws_999.cgi (Korean)
  36. Korean Ministry of Labor. Statistics for Wage Structure, 2002 (Korean)
  37. Korea National Statistics Office. Age- and Gender-specific Population Size 2003 (Korean)